Skip to main content
Premium Trial:

Request an Annual Quote

Strong RT-PCR, Mass Spec Sales Drive Applied Biosystems Q1 Revenue; Sequencing Declines

NEW YORK, Oct. 26 (GenomeWeb News) - Applied Biosystems today reported an increase in revenues and income for its fiscal first quarter, driven by growing sales of its real-time PCR and other applied genomics products, while DNA sequencing revenues declined.


Total revenues for the three months ended Sept. 30 increased to $390.3 million from $382.7 million during the same period last year. Revenues from real-time PCR and other applied genomics soared to $111.8 million, from $94.3 million last year. Mass spectrometry sales also increased, totaling $89.1 million compared to $82.4 million last year.


Revenues from the three other product categories declined: DNA sequencing revenues sank to $116.1 million from $124.8 million; core DNA synthesis and PCR revenues declined to $47.4 million from $51.2 million, and revenues from other product lines fell to $25.9 million from $30 million.


R&D spending amounted to $51.1 million for the quarter, down from $59.6 million during the year-ago period. This decrease resulted from ABI's recent alignment of its R&D product portfolio, the company said.


ABI's net income for the quarter was $37.1 million, or $.19 per basic share, up from $33.4 million, or $.16 per basic share, for the year-ago quarter. Part of this increase -- $800,000 -- was due to income from a patent-infringement settlement and from the termination of a joint development agreement with Illumina, partially offset by severance charges fromm staff reductions.


ABI did not state its assets in its quarterly financial report.

The Scan

Researchers Develop Polygenic Risk Scores for Dozens of Disease-Related Exposures

With genetic data from two large population cohorts and summary statistics from prior genome-wide association studies, researchers came up with 27 exposure polygenic risk scores in the American Journal of Human Genetics.

US Survey Data Suggests Ancestry Testing Leads Way in Awareness, Use of Genetic Testing Awareness

Although roughly three-quarters of surveyed individuals in a Genetics in Medicine study reported awareness of genetic testing, use of such tests was lower and varied with income, ancestry, and disease history.

Coral Genome Leads to Alternative Amino Acid Pathway Found in Other Non-Model Animals

An alternative cysteine biosynthesis pathway unearthed in the Acropora loripes genome subsequently turned up in sequences from non-mammalian, -nematode, or -arthropod animals, researchers report in Science Advances.

Mosquitos Genetically Modified to Prevent Malaria Spread

A gene drive approach could be used to render mosquitos unable to spread malaria, researchers report in Science Advances.